Veliparib (ABT-888), Bendamustine, and Rituximab (VBR) Is Well Tolerated and Efficacious in Patients with Lymphoma: Final Analysis of a Phase 1b Clinical Trial of VB and a Cohort Expansion of Vbr in Patients with B-Cell Lymphoma
| Autor: | Soumerai, Jacob D, Zelenetz, Andrew D, Moskowitz, Craig H, Younes, Anas, Palomba, Maria Lia, Hamlin, Paul A, Jr., Noy, Ariela, Horwitz, Steven M, Matasar, Matthew J., Moskowitz, Alison J, Portlock, Carol S, Straus, David J, Chen, Alice *, Little, Richard F, France, Fallon *, Whang, Juho *, Mishra, Nishant *, Jarjies, Christine *, Gerecitano, John F |
|---|---|
| Zdroj: | In Blood 3 December 2015 126(23):2691-2691 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|